Hull Charles W
- SEC CIK
- 0001105964
No open-market purchases or sales filed in the past year.
Current role at each company
- DDD 3D Systems CorpEVP & Chief Technology Officeras of Sep 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hull Charles W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2024 (view filing) | Dec 17 | 1 day | Hull Charles WEVP & Chief Technology Officer | SSale | −116.0K | $3.86 | −$447.6K | −25.9%332.0K after | |
| Jun 10, 2022 (view filing) | Jun 8 | 2 days | Hull Charles WEVP & CTO (Regenerative Med) | SSale | −26.4K | $10.95 | −$288.9K | −33.8%51.6K after | |
| Mar 9, 2022 (view filing) | Mar 8 | 1 day | Hull Charles WEVP & CTO (Regenerative Med) | SSale | −13.2K | $14.77 | −$195.3K | −18.1%59.9K after | |
| Mar 9, 2022 (view filing) | Mar 7 | 2 days | Hull Charles WEVP & CTO (Regenerative Med) | SSale | −16.4K | $14.78 | −$242.2K | −3.5%447.9K after |